2016newlogowords
November AACT ABAT Webinar “Going with the Flow: Filtering Through the Evidence for Fomepizole Dosing in Patients Receiving Renal Replacement Therapy”
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
Was the educational content of value to you?
Was the educational content scientifically sound?
If no, please explain...
Did you perceive any commercial bias or influence in the educational content?
If yes, please explain...
Did this activity improve your Skills or Strategy?
If yes, how...
Do you think what you learned will benefit you in your practice?
If yes, how...
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
What questions are you having in your practice that you would like to see addressed in an educational activity?
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924: 
Please rate Kristen Charity O'Brien
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Please rate Jeremy Lund
Independence, Objectivity, Balance, Scientific Rigor
Relevance of Content to Objectives
Presentation/Handouts
Content/Teaching Methods
Were the learning objectives met?

Differentiate between published recommendations for fomepizole dosing in patients receiving different renal replacement strategies

Describe the pharmacokinetics of fomepizole in CRRT
Compare fomepizole pharmacokinetics in healthy human subjects and patients with methanol and ethylene glycol poisoning
Assess the effect of hemodialysis on clearance of fomepizole in methanol- and ethylene ylgcol-poisoned patients
When you viewed this webinar, were you in a group or by yourself?
If in a group, with how many people?
Comments:
Mr question
Provided by amedco